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Abstract 
 
Objective:  Osteoarthritis is a leading cause of disability.  This systematic review aimed to establish 
the prevalence of depressive symptoms and anxiety among people with osteoarthritis in comparison to 
those without osteoarthritis.  
 
Method: We systematically reviewed databases including AMED, EMBASE, MEDLINE, PsycINFO, 
BNI, CINAHL and the Cochrane database library from their inception to January 2015. Studies 
presenting data on depressive symptoms and anxiety in people with osteoarthritis were included. A 
random and fixed-effect meta-analysis was conducted on all eligible data.   
 
Results:  A total of 49 studies were included, representing 15,855 individuals (59% women; mean age 
65.2 years). The evidence-base was moderate in quality. The pooled prevalence of depressive 
symptoms in osteoarthritis was 19.9% (95% Confidence Intervals (CI): 15.9% to 24.5%, n=10,811). 
The corresponding pooled prevalence was 21.3% (95% CI: 15.5% to 28.5%; n=1,226) for anxiety 
symptoms. The relative risk of depression among people with osteoarthritis was 1.17 (95% CI 0.69 to 
2.00, 3 studies, n=941) compared to people without osteoarthritis.  The relative risk of anxiety was 
1.35 (95% CI: 0.51 to 3.59; 3 studies, n=733) compared to those without osteoarthritis.  
 
Conclusion: One fifth of people with osteoarthritis experience symptoms of depression and anxiety. 
However it is uncertain whether this is increased compared to those without osteoarthritis, with no 
direct evidence to support an increase in anxiety and depression in osteoarthritis. 
 
Keywords: Osteoarthritis; degenerative; psychological; mood; pain 
 
PROSPERO Registration Number: CRD42013006733 
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Introduction 
 
Osteoarthritis is a chronic, degenerative, musculoskeletal disease with global prevalence of 10% of 
men and 20% of women greater than 60 years [1]. Whilst life expectancy has increased globally [2, 3], 
people are also experiencing more years lived with disability due to such musculoskeletal conditions 
[4].  Osteoarthritis often has a profound impact on an individual’s health and wellbeing since it is 
associated with increased pain, decreased function and elevated disability [5, 6], with the concomitant 
difficulties experienced in maintaining activities of daily living [7] and subsequent reductions in 
quality of life [8]. Thus, it is unsurprising that people with osteoarthritis are at greater risk of 
experiencing mental health problems [9-11].  A substantial body of literature has established that 
chronic pain, a common feature with osteoarthritis, is associated with depressive and anxiety 
symptoms [10, 11]. 
 
Recently, the importance of major depression, depressive symptoms and anxiety among people with 
osteoarthritis has gained increasing recognition [7]. Depressive symptoms were highlighted as a 
potential barrier to physical activity for people with osteoarthritis in a recent systematic review [12]. 
This is important as physical activity has been demonstrated to reduce pain and disability in this 
population [13]. Gleicher et al [14] reported that among a cohort of over 2,000 individuals with 
probable osteoarthritis, 29% had probable depression yet almost half did not receive any mental 
healthcare support.  This is despite a recent evidence suggesting that cognitive behavioural therapy, 
exercise and integrated depression management may improve outcomes for those with osteoarthritis 
and comorbid depression [15].   
 
A recent review established that depressive symptoms were highly prevalent among people with 
rheumatoid arthritis and associated with poorer outcomes [16].  It remains unclear if this extends to 
osteoarthritis. However, no study to date has attempted to systematically review and quantify the 
prevalence of depression and anxiety in osteoarthritis through meta-analysis techniques. We therefore 
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aimed to address this limitation and to provide robust evidence on clinical relevance and importance 
of symptoms of depression and anxiety in osteoarthritis.  
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Materials and Methods 
 
This systematic review was conducted within the Reporting Items for Systematic reviews and Meta-
Analyses (PRISMA; [17]) statement and followed a predetermined registered protocol (PROSPERO: 
CRD42013006733).   
 
Search Strategy 
 
Three authors (BS, YA, TO) searched major electronic databases (AMED, EMBASE, MEDLINE, 
PsycINFO, BNI, CINAHL, the Cochrane library), grey literature and trial databases (OpenGrey 
(System for Information on Grey Literature in Europe), WHO International Clinical Trials Registry 
Platform, Current Controlled Trials and the United States National Institute of Health Trials Registry) 
from inception until 14th January 2015.  The search terms used for the MEDLINE search are 
presented as Supplementary Table 1 and these were modified for each database.  We conducted 
citation chasing search strategy with all reference lists of included articles and relevant review papers 
were considered to identify potentially omitted articles.  Finally, all corresponding authors were 
emailed to consult whether any currently unpublished or previously unidentified papers could be 
incorporated into the final review. 
 
Eligibility Criteria 
 
Studies were eligible if they met the following criteria: a) case control, cohort or intervention studies 
(using baseline data only) with or without a comparison group without osteoarthritis; b) reported the 
prevalence, incidence or relationship of major depression, depressive symptoms and/ or anxiety in 
adults diagnosed with osteoarthritis of any joint. We accepted studies that diagnosed major depression 
through a structured clinical interview (the gold standard) and also those that defined depressive 
symptoms through an appropriate screening measure, for example the Patient Health questionnaire 
(PHQ, [18]).  We accepted a diagnosis of osteoarthritis determined through a combination of clinical 
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signs and symptoms and/or radiological evidence of degenerative osteoarthritis changes in line with 
recognised international criteria (American College of Rheumatologists; [19]).  
 
We excluded single-case studies and animal studies but did not exclude studies based on the year or 
language of publication. Studies which recruited people with non-osteoarthritis diagnoses such as 
rheumatoid arthritis, fibromyalgia or chronic pain were excluded. Papers reporting depressive 
symptoms and anxiety in cohorts with joint replacement (arthroplasty) were excluded. If we 
encountered studies with participants with mixed diagnosis (e.g. some with osteoarthritis and 
rheumatoid arthritis) we contacted the authors to acquire the osteoarthritis specific data.  If we 
encountered multiple publications from the same cohort, we used the data from the most recent and/or 
paper reporting data from the largest number of participants.  
 
Study Identification 
 
Two authors (BS, YA) independently reviewed the titles and abstracts from potentially relevant 
papers identified through the search strategy. The full-text of all potentially eligible papers were 
reviewed independently by the two authors (BS, YA) before making a final decision on eligibility. 
Any disagreements in paper eligibility were resolved through a third reviewer (TS).  
 
Outcome Measures 
 
The outcomes of interest were major depression diagnosed with a structured clinical assessment (e.g. 
DSM-IV [20] or ICD 10 or depressive symptoms and/or anxiety assessed with a validated assessment 
tool or screening measure (for example the Hospital Anxiety and Depression Scale, Centre for 
Epidemiologic Studies Depression Scale or Geriatric Depression Scale, CES-D).   
 
Data Extraction 
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Two authors (BS, YA) independently extracted data. The data extracted included characteristics of 
study participants, details of osteoarthritis (method of diagnosis, severity according to pain on a visual 
analogue scale (VAS), functional impairment e.g. Western Ontario and McMaster Universities 
(WOMAC) or radiological details such as Kellgren-Lawrence scale) [21] details of comorbidities, 
method of assessing depression/anxiety and the results.  Wherever possible, we extracted the number 
affected and not affected by depression/depressive symptoms/anxiety in each sample (using the 
authors’ cut off points for each outcome measure). If this was not available, we extracted the mean 
and standard deviation of the depression/anxiety assessment scale.  
 
Critical Appraisal 
 
Two authors (BS, YA) critically appraised each included paper using a tool based on the  CASP ‘Case 
Control’ and ‘Cohort’ appraisal tools (CASP, [22]). Studies were classified as high, moderate and low 
quality using the threshold values of low (0-5 points), moderate (6-8 points) and high (9-10 points). 
Any disagreements in data extraction and appraisal were resolved through discussion between the two 
reviewers (BS, YA), or adjudication with a third reviewer (TS).  
 
Data Analysis 
 
Three analyses were undertaken. First, we pooled studies reporting the prevalence of depression 
(including depressive symptoms) and anxiety in the osteoarthritis sample using a random effects 
meta-analysis.  Second, we conducted a meta-analysis using a pooled relative risk (RR) analysis with 
random-effect (RE) model to compare the risk of depressive symptoms and anxiety in osteoarthritis 
and non-osteoarthritis cohorts. Third, when studies reported mean scores for the depressive symptoms 
and anxiety, we conducted a pooled standardised mean difference (SMD) analysis to investigate 
differences between those with and without osteoarthritis. Statistical heterogeneity was assessed using 
I2 statistical test [23]. Publication bias was assessed with a visual inspection of a funnel plot and the 
Egger’s bias value. 
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Wherever possible, subgroup analyses were conducted to assess the difference in symptoms of 
depression and anxiety between those who present with OA of different joints e.g. knee vs. hip, and 
those presenting with multiple joint symptoms. A subgroup analysis was also undertaken to compare 
results from studies conducted with cohort from the United States of America (USA) compared to 
Europe. Sensitivity analyses were undertaken when there were sufficient numbers of studies 
presenting with variation in study quality. In such instances, we compared the meta-analysis findings 
from high, moderate and low quality studies. Finally, a meta-regression was undertaken to explore the 
influence of age on prevalence of depression and the influence of study quality on the prevalence of 
depression and anxiety in people with osteoarthritis. 
 
Statistical analyses were conducted on RevMan (Review Manager) Version 5.1 (Copenhagen: The 
Nordic Cochrane Centre, The Cochrane Collaboration, 2011), STATA version 11.0 (StataCorp LP, 
Texas, USA) and statsdirect (Statsdirect ltd, Chester, UK).   
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Results 
 
Search Results 
 
A total of 445 citations were identified. From this, 109 were potentially eligible and considered in the 
full-text review. Sixty articles were excluded, thus 49 records met the eligibility criteria and were 
included. A summary of the search results is presented in Figure 1.  
 
Critical Appraisal 
 
A summary of the critical appraisal results are presented in Supplementary Table 2. As this represents, 
the evidence-base was largely moderate in quality. On specific assessment of the criteria, the 
evidence-base was largely strong in relation to clearly presenting a research question (n= 48 studies) 
and recruitment of clearly defined cohorts through transparent approach (n=49). However, recurrent 
limitations to the evidence-base included not clearly defining and then adjusting for all important 
confounding factors such as age, co-morbidities and severity of osteoarthritis, as seen in 27 studies.  
 
Characteristics of Included Studies 
 
A summary of the included study characteristics is presented in Supplementary Table 3. A total of 
15,855 participants were included in the 49 papers with a mean age of 65.2 years (Standard Deviation: 
5.2). This included 5,382 males and 9,422 females; the gender-mix was not presented in four studies 
representing 1,051 individuals [20-23]. The most frequently assessed anatomical region of 
osteoarthritis was the knee (n=24), followed by mixed lower limb osteoarthritis (n=12) and hip and/or 
knee osteoarthritis together (n=9). Two studies solely assessed people with hip osteoarthritis, whilst 
one study assessed people with hand osteoarthritis. A single study did not classify the anatomical 
region of their cohort with osteoarthritis [24]. Only ten studies reported the duration of symptoms, 
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ranging from 5.3 months [25] to 19 years [23].  
 
Most studies were conducted in the United States of America (USA, n=20). Other studies were 
conducted in the UK (n=5), Turkey (n=4), Canada (n=4) and Taiwan (n=3).  Individual studies were 
conducted in Ireland, Brazil, New Zealand, Germany, Finland and Korea. 
 
The methods employed to assess anxiety and depressive symptoms, and the frequency of their use are 
presented in Supplementary Table 4.  
 
Thirteen studies reported details regarding the type or frequency of comorbidities among participants. 
From the studies which assessed co-morbidities, the number ranged from 2.1 [26] to 3.1 [27]. When 
the specific type of co-morbidity was presented, the most commonly presented were hypertension, 
metabolic disorders, cardiovascular disease, diabetes mellitus and osteoporosis [28,29]. The mean 
VAS pain score for the cohorts was presented in 14 studies and was 4.28 (SD=1.5) ranging from 2.4 
[30] to 6.4 [31].  
 
Meta-Analysis 
A summary of the meta-analysis results are presented in Supplementary Table 5 and Supplementary 
Table 6. 
 
Publication Bias 
 
Figure 2 demonstrated an asymmetrical funnel-plot for the prevalence of depressive in people with 
osteoarthritis, suggesting evidence of some publication bias although quantitative testing with Egger 
bias confirmed this was not significant (intercept 1.2, p=0.5).  Individual egger bias test scores are 
presented for each analysis in Supplementary Table 5.    
 
Depressive symptoms 
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Prevalence and relative risk of depressive symptoms in people with osteoarthritis  
 
A summary of the prevalence data for osteoarthritis and depressive symptoms is presented in 
Supplementary Table 5. In brief, data from 24 studies (n=10,506) established the pooled prevalence of 
depressive symptoms in people with osteoarthritis was 19.9% (95% CI: 15.9% to 24.5%; I2: 96.1%; 
Figure 3).  The prevalence of depressive symptoms was 15.6% (95% CI: 8.3% to 27.2; N=4), 20.5% 
(95% CI: 15.1% to 27.3%) and 21.1% (95% CI: 13.4% to 31.6%) in low, medium and high quality 
studies respectively (Figure 3).   
 
The pooled prevalence of depressive symptoms across 11 studies (n=6722) in adults with isolated 
knee osteoarthritis was 18.5% (95% CI: 13.8% to 23.7%; I2: 85.4%).  The prevalence was 23.0% 
(95% CI: 16.4% to 30.2%; I2: 95.8%) among 4,039 people with mixed lower limb osteoarthritis. 
There was a greater prevalence of depressive symptoms in people with osteoarthritis from studies 
conducted in the USA (23.1%; 95% CI: 14.6% to 32.8%; I2: 95.8%) compared to Europe (19.9%; 
95% CI: 15.8% to 24.3%; I2: 90%). 
 
Four studies included data on depressive symptoms for people without osteoarthritis.  A pooled 
relative risk (RR) of 0.49 (95% CI: 0.10 to 2.45; I2: 96.5; n=1490; Supplementary Figure 1) was 
established. Visual inspection of the forest plot demonstrated that one study was an obvious outlier 
[32].  Therefore, in a sensitivity analyses this low quality study was removed and the pooled relative 
risk was 1.17 (95% CI: 0.69 to 2.00) among 3 medium quality studies.   
 
Depressive symptoms in osteoarthritis versus non-osteoarthritis cohorts 
 
Four studies (n=736) presented data comparing depressive symptoms scores for people with 
osteoarthritis compared to those without osteoarthritis. No significant differences were observed in 
studies using the GDS or CES-D (SMD: 0.64; 95% CI: -0.24 to 1.52).  There was no significant 
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difference in the CES-D either when assessing people with isolated knee osteoarthritis (MD: 0.83, 
95% CI: -0.62 to 2.29). 
 
Meta-Regression of Age and Study Quality on Depression 
 
Neither mean age of the osteoarthritis samples nor study quality moderated for the prevalence of 
depression in the meta-regression analysis (Age: p=0.75; goodness of fit: I2=95.0%; Study Quality: 
p=0.71; goodness to fit: I2=96.1%). However, mean age explained some of the statistical 
heterogeneity observed in the results (R2=0.12). Study quality did not explain the statistical 
heterogeneity (R2=0.02). 
 
Anxiety symptoms 
 
Prevalence of anxiety symptoms in osteoarthritis cohorts 
 
A summary of the prevalence data for osteoarthritis and anxiety is presented in Supplementary Table 
6. The pooled prevalence of anxiety symptoms across seven studies (n=1,226) among people with 
osteoarthritis was 21.3% (95% CI: 15.5% to 28.5%; I2: 88.9%; Figure 4).   The pooled prevalence of 
anxiety symptoms across four studies including 665 individuals with isolated knee osteoarthritis was 
15.8% (95% CI: 7.5% to 25.1%; I2: 87.7%).  The prevalence of anxiety was 28.2% (95% CI: 23.0% to 
33.8%; I2: 12.6%) among 315 people with lower limb osteoarthritis.  It was possible to undertake a 
subgroup analysis to assess the prevalence of anxiety in people with osteoarthritis from studies 
undertaken in Europe alone. This reported a prevalence of 26.6% (95% CI: 21.1% to 32.4%; I2: 72.1% 
n=999). 
 
The relative risk of anxiety was 1.35 (95% CI: 0.51 to 3.59; I2: 52.4; n=733; Supplementary Figure 2) 
indicating no significant differences in anxiety. Caution should be attached to this as only two studies 
were included in the comparative analysis.   
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Anxiety symptoms score in osteoarthritis versus non- osteoarthritis cohorts 
 
No studies provided data to compare anxiety symptoms scores for people with osteoarthritis compared 
to those without in case-controlled studies. 
 
Meta-Regression of Study Quality on Anxiety 
 
Study quality did not moderate the prevalence of anxiety in the meta-regression analysis (p=0.51; 
goodness to fit: I2=87.3%). However, study quality explained some of the statistical heterogeneity 
observed in the results (R2=0.24).  
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Discussion 
 
Our results suggest that people with osteoarthritis experience concerning levels of depressive 
symptoms (approximately 20%). These findings mirror that of the rheumatoid arthritis population 
where depression has been reported as highly prevalent [16].  However, it remains unclear if people 
with osteoarthritis are at a higher risk of experiencing depressive symptoms compared to general 
population, because of the paucity of comparative data.  Furthermore, around a fifth of people with 
osteoarthritis also experience anxiety, but again it is unclear if this elevated compared to people 
without osteoarthritis due to the paucity of studies that provided comparative data.   
 
These results did not find any direct evidence to support an increase in anxiety and depression in 
people with osteoarthritis. However the results reported higher depression and anxiety than previous 
population estimates where the prevalence of clinically relevant depression has been estimated at 15% 
[32] and anxiety 8% to 10% [33] in older people. The prevalence of these psychiatric morbidities is 
important in osteoarthritis since depressive symptoms may be a better predictor of disability than 
radiographic evidence of degenerative joint changes in people with osteoarthritis [34,35].  Secondly, 
depression is associated with heightened pain and increased functional disability [36]. Thirdly, 
depressive symptoms are associated with a drastically reduced quality of life, and are potential 
barriers to physical activity and social participation [7, 12]. Fourthly, depression is associated with a 
marked increased risk of falls in older people [37], which remain a leading cause of morbidity, 
admission to long-term care facilities and mortality [38]. Finally, individuals with osteoarthritis 
perceived as a disability appear more strongly related to depressive symptoms than actual functional 
performance [39].  Accordingly clinicians should be mindful of the importance of detection and 
multidisciplinary treatment of depression and anxiety in people with osteoarthritis [36].  
 
The results of this review can be interpreted through considering possible mechanisms to explain the 
association between depressive symptomology and osteoarthritis. Both depression and osteoarthritis 
are associated with inflammation and exercise may also reduce inflammation [40]. Moreover, a recent 
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meta-analysis [41] demonstrated that nonsteroidal anti-inflammatory drugs (NSAIDs) significantly 
reduce depressive symptoms and may also be an important treatment option for those with pain 
symptoms.  
 
Whilst this is the first review of its type, several limitations should be acknowledged.  First, there was 
inadequate data to conduct subgroup analyses according to variables of interest such as gender, 
duration of osteoarthritis symptoms, number of joints affected, severity of pain, or impact of age (e.g. 
<65 and 65> years).  Second, almost all of the included studies defined depressive symptoms with a 
screening tool but accuracy and utility of these instruments in people with osteoarthritis is 
undetermined.  Lastly, there was evidence of some heterogeneity in some of the analyses, which was 
only partially accounted for in meta-regression analyses.   
 
To conclude, people with osteoarthritis experience high levels of depressive symptoms and anxiety. 
This appears to be higher than the general population of a similar age [32,33]. This is of high 
relevance as both have the potential to have a severe and deleterious impact on an individual’s health 
and increase health-service utilisation. Clinicians should be mindful of these disorders in the 
management of people with osteoarthritis since they have the potential to exacerbate symptoms and 
have a detrimental effect on the quality of life and prognosis of this growing patient population. 
However further research with better designed comparative studies of age, gender and medical-
morbidity matched cohorts are needed in community cohorts before recommendations are made for 
targeted screening and interventions for people with osteoarthritis. Indeed routine assessment of 
depression and anxiety could be argued to be part of the assessment of all people presenting with a 
chronic health conditions. Given the possible bi-directional nature of association and impact between 
physical and mental health it would require to explore whether detecting and treating these mental 
health issues or better management of associated physical co-morbidities in these patients has 
significant benefits for patients.   
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Figure and Table Legends 
 
 
Figure 1: PRISMA Flow-Chart. 
Figure 2: Funnel-Plot: Prevalence of depression in osteoarthritis 
Figure 3: Forest-plot of prevalence of depressive symptoms in people with osteoarthritis (ordered 
descending with the highest mean age the first plot). 
Figure 4: Forest-plot of prevalence of anxiety in people with osteoarthritis (ordered descending with 
the highest mean age the first plot). 
 
Supplementary files 
Supplementary Table 1: Search strategy for MEDLINE search (adopted for individual databases). 
Supplementary Table 2: Summary of the critical appraisal results using the modified CASP tool. 
Supplementary Table 3: Characteristics of included study table. 
Supplementary Table 4: Assessment tools for anxiety and depression. 
Supplementary Table 5: Meta-Analysis results of prevalence of depression. 
Supplementary Table 6: Meta-Analysis results of prevalence of anxiety. 
 
Supplementary Figure 1: Forest-plot of relative risk of depressive symptoms for people with 
osteoarthritis. 
Supplementary Figure 2: Forest-plot of relative risk of anxiety for people with osteoarthritis. 
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Figure 1: PRISMA Flow-Chart 
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Figure 2: Funnel-Plot: Prevalence of depression in osteoarthritis 
 
 
RR – relative risk; SE (log[RR] – standard error (log relative risk) 
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Figure 3: Forest-plot of prevalence of depressive symptoms in people with osteoarthritis (grouped 
according to study quality). 
 
Group by
Study quality
Study name Event rate and 95% CI
Event Lower Upper 
rate limit limit
1 Low Possley 2009 0.419 0.329 0.515
1 Low Leite 2011 0.385 0.291 0.488
1 Low Perrots 2011 0.054 0.026 0.109
1 Low Creamer 2000 0.029 0.016 0.052
1 Low 0.156 0.083 0.272
2 Medium Blixen 1999 0.460 0.328 0.598
2 Medium Miguel 2012 0.345 0.234 0.475
2 Medium O'Reilly 1998 0.300 0.251 0.354
2 Medium Broderick 2011 0.275 0.213 0.347
2 Medium Ozcakir 2011 0.270 0.192 0.365
2 Medium Ellis 2012 0.260 0.197 0.335
2 Medium Ataoglu 2003 0.259 0.176 0.365
2 Medium Rosemann 2007 0.192 0.169 0.217
2 Medium Hawker 2011 0.174 0.144 0.209
2 Medium Pereira 2013 0.160 0.134 0.190
2 Medium Tonelli 2011 0.152 0.101 0.222
2 Medium Juhakoski 2008 0.114 0.060 0.205
2 Medium Memel 2000 0.083 0.050 0.136
2 Medium Hsieh 2013 0.041 0.013 0.120
2 Medium 0.205 0.151 0.273
3 High McCurry 2011 0.429 0.391 0.468
3 High Axford 2010 0.278 0.175 0.411
3 High Duivenvoorden 2013 0.258 0.217 0.304
3 High Wilkie 2013 0.157 0.136 0.180
3 High Riddle 2011 0.130 0.118 0.142
3 High White 2012 0.123 0.107 0.142
3 High 0.211 0.134 0.316
Overall 0.198 0.157 0.247
-0.50 -0.25 0.00 0.25 0.50
Prevalence depressive symptoms  
Note: the horizontal axis refers to the prevalence of depressive symptoms.  0.00 = 0% through to 0.50 
which equates to 50%.   
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Figure 4: Forest-plot of prevalence of anxiety in people with osteoarthritis (ordered by increasing 
study quality with the lowest study quality plotted first). 
Study name Event rate 
and 95% CIEvent Lower Upper 
rate limit limit
Perrots 2011 0.323 0.236 0.424
Memel 2000 0.244 0.185 0.315
O'Reilly 1998 0.297 0.248 0.351
Ellis 2012 0.110 0.070 0.170
Hsieh 2013 0.041 0.013 0.120
Axford 2010 0.315 0.206 0.449
Duivenvoorden 2013 0.193 0.156 0.235
0.213 0.155 0.285
-0.50 -0.25 0.00 0.25 0.50
Prevelance anxiety symptoms
 
Note: the horizontal axis refers to the prevalence of depressive symptoms.  0.00 = 0% through to 0.50 
which equates to 50%.   
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Supplementary Table 1: Search strategy for MEDLINE search (adopted for individual databases) 
 38 
 
1. Osteoarthritis 
2. Degenerative 
3. OR/1-2 
4. exp. Joint/ 
5. Limb.ti.ab 
6. Spine.ti.ab 
7. Back.ti.ab 
8. Neck.ti.ab 
9. Hip.ti.ab 
10. Knee.ti.ab 
11. Ankle.ti.ab 
12. Foot.ti.ab 
13. Toe.ti.ab 
14. Shoulder.ti.ab 
15. Elbow.ti.ab 
16. Wrist.ti.ab 
17. Hand.ti.ab 
18. Finger.ti.ab 
19. OR/4-18 
20. Anxiety/ 
21. Anxious.tw. 
22. Panic disorder/ 
23. Depression/ 
24. Depressed.ti.ab 
25. Psychopathological.ti.ab 
26. Psychological Factors/ 
27. Psychology/ 
28. Psychiatr$.ti.ab 
29. Mental health/ 
30. OR/20-29 
31. AND/3,19,30 
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Supplementary Table 2: Summary of the critical appraisal results using the modified CASP tool 
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[5
3
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Did the study address a clearly focused issue?             
Was the cohort recruited in an acceptable way?             
Was the exposure accurately measured to minimize bias?             
Was the outcome accurately measure to minimize bias?             
Have the authors identified all important confounding factors?  X   X X X  X  X  
Was the follow up of the subjects complete enough?  N/C  N/C  X X X  N/C   
Was the follow up of subjects long enough? X N/C N/C N/C  X X N/C X N/C X X 
Where confidence intervals presented? X  X  X X X x X X X X 
Were the results generalisable to the general population?  X    X X N/C X X X X 
Do the results of this study fit with other available evidence?  X        X   
Overall Methodological Quality M L M H M M M M M L M M 
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Did the study address a clearly focused issue?           N/C  
Was the cohort recruited in an acceptable way?             
Was the exposure accurately measured to minimize bias?       X      
Was the outcome accurately measure to minimize bias?           N/C  
Have the authors identified all important confounding factors?  X    X  X   N/C N/C 
Was the follow up of the subjects complete enough?       N/C    N/C  
Was the follow up of subjects long enough?  X  X X   X N/C  N/C  
Where confidence intervals presented? X X  X X     X X X 
Were the results generalisable to the general population?  X X X X  N/C X X  N/C X 
Do the results of this study fit with other available evidence?    X X    X    
Overall Methodological Quality H  M H  M   M H  M  M M  H L M  
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Did the study address a clearly focused issue?             
Was the cohort recruited in an acceptable way?             
Was the exposure accurately measured to minimize bias?   X N/C     X     
Was the outcome accurately measure to minimize bias?         X X   
Have the authors identified all important confounding factors?     x X    X X  
Was the follow up of the subjects complete enough? X x N/C X  X     X  
Was the follow up of subjects long enough?   N/C X     X N/C X  
Where confidence intervals presented? X  X X   X X X  X  
Were the results generalisable to the general population?  x  X N/C X N/C   N/C   X  
Do the results of this study fit with other available evidence?      X       
Overall Methodological Quality H  M M  L  M M  M M  L M  L  H  
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Did the study address a clearly focused issue?              
Was the cohort recruited in an acceptable way?              
Was the exposure accurately measured to minimize bias?   N/C  X X        
Was the outcome accurately measure to minimize bias?   N/C   X        
Have the authors identified all important confounding 
factors? 
  X   X N/C X X X X   
Was the follow up of the subjects complete enough? X   X  N/C  X   X   
Was the follow up of subjects long enough? X X  X N/C X  X N/C     
Where confidence intervals presented? X X X X X X X X X X X   
Were the results generalisable to the general population?   X   X  X X X X   
Do the results of this study fit with other available 
evidence? 
X      X  X     
Overall Methodological Quality M M L M M L M L L M M H H  
 - yes; x – no; N/C – Not Clear 
Methodological Quality: 9-10/10 = (H) high; 6-8/10 = (M) moderate; 5-0/10 = (L) low 
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Supplementary Table 3: Characteristics of included study table 
Study Study design Study country 
of origin 
Joint(s) affected 
by OA 
Total sample 
size (OA 
participant) 
Gender 
(m/f) 
Mean Age in 
years (range or 
SD) 
Mean Duration 
of symptoms  
(Months) 
Source of recruitment 
(community/hospital) 
Akyol et al [46] RCT Turkey Knee 40 (40) 
 
0/40 57.8 (10.6) 
56.6  (8.1) 
N/S Hospital 
Appelt et al [47] Cohort USA Hip/ knee 591 (591) 591/0  66 (N/S) N/S Hospital 
Ataoglu et al [48] Cohort Turkey  Knee 81 (81) 36/45 52.7 (8.6) 6.33 Hospital 
Axford et al [36] Cohort UK Lower limb 54 (54) 12/42 63.3 (N/S) N/S Hospital 
Axford et al [43] Cohort UK Mixed  170 (170) 59/111 63 (32-83) N/S Hospital 
Blixen et al [23] Cohort USA Mixed 50 (50) N/S 70.5 (6.3) 228 Hospital 
Brandt et al [49] Cohort USA Knee 173 (173) 85/84 71.6 (1.1) 
70.1 (0.6) 
N/S Hospital 
Broderick et al [50] Cohort USA Hip and knee 171 (171) 43/128 66.3 (9.5) 13.1 Hospital 
Chiou et al [51] Cohort Taiwan Mixed 69 (69) 20/49 68 (5.5) 7.1 Hospital 
Creamer et al [34] Case-Control USA Knee 374 (90) 21/48 65.8 (10.4) N/S Community 
Cruz-Almeida et al [52] Cohort USA Knee 194 (194) 60/134 57 (7.7) N/S Hospital 
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DeVellis et al [53] Cohort USA Mixed  90 (90) 18/72 71 (N/S) N/S Community 
Duivenvoorden et al [54] Cohort Holland Knee 384 (384) 
 
150/234 67.9 (9.6) 
66.2  (9.7) 
N/S Hospital 
Ellis et al [55] Cohort USA Knee  154 (154) 44/110 60.4 (8.9) N/S Hospital 
French et al [26] RCT Ireland Hip 131 (131)
  
47/84 61.94 (9.93) 34.81  Hospital 
Gandhi et al [56] Cohort Canada Hip or knee 200 (200) 
 
81/119 
 
62.7 (10.6) 
66.5 (8.4) 
N/S Hospital 
Hawker et al [57] Cohort Canada Hip or knee 529 (529) 130/399 75.4 (56.7-95.8) N/S Community 
Hodkinson et al [58] Cohort France Hand 138 (138) 17/155 64.2 (8.7) 9.0  Hospital 
Hoogeboom et al [59] Cohort Holland Hip or knee 401 (401) 170/231 58 (13) N/S Hospital 
Hsieh et al [60] Case-Control Taiwan Knee 123 (73) 10/63 60.3 (10.4) N/S Hospital 
Juhakoski et al [61] Cohort Finland  Hip 118 (118) 36/ 84 Range: 55 to 80 N/S Hospital 
Kim et al  [62] RCT Korea Mixed 556 (226) 64/492 73.3 (5.6) N/S Hospital 
Leite et al [29] Cohort France Mixed 91 (91) 8/83 59.3 (38-85) N/S Hospital 
Maly et al [63] Cohort Canada Knee 54 (54) 22/32 68.3 (8.7) N/S Hospital 
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McCurry et al [64] Cohort USA Mixed 834 (834) 
 
198/636 72.9 (8.2) 
70.8  (9.3) 
N/S Community 
Memel et al [65] Cohort UK Hip or knee 177 (177) 59/118 71 (42.92) N/S Hospital 
Miguel et al [27] Cohort Brazil Hip/ or knee 58 (58) 4/54 Non frail (17) 
74 ± 5 
Pre frail (28) 
73 ± 6 
Frail (13) 
75 ± 6 
N/S Community 
Morone et al [66] RCT USA Knee 88 (88) 40/48 71.5 (5.4) N/S Hospital 
O’Reilly et al [21] Case-Control UK Knee 600 (300) N/S 61.3 (10.4) N/S Community 
Ozcakir et al [28] Cohort Turkey Knee 100 (100) 17/83 59.5 (0.9) 7.7 Hospital 
Parmelee et al [24] Cohort USA N/S 367 (367) 133/234 67.89 (9.73)  N/S Hospital 
Pereira et al [20] Cohort Portugal Knee 663 (663) 292/371 58.0  (15.2) N/S Community 
Perrot et al [67] Cohort France Hip or Knee 129 (129) 36/93 67.7 (10.0) N/S Hospital 
Perruccio et al [68] Cohort Canada Knee 494 (494) 171/323 64.9 (35-88) N/S Hospital 
Possley et al [69] Cohort USA Knee 105 (105) 93/12 67.5 (8.4) N/S Hospital 
Riddle et al [70] Cohort USA Knee 3047 (3047) 1032/2015 60.62 (9.04) N/S Community 
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Rosemann et al [71] Cohort Holland Knee or Hip 1021 (1021) 347/ 674 66.1 (15.1) 13.7  Community 
Scopaz et al [72] Cohort USA Knee 182 (182) 60/122 63.90 (8.8) 
 
N/S Hospital 
Sherman et al [73] Cohort USA Knee 285 (285) 
 
139/146 71 (4.6) 
71.5 (4.4) 
71.0 (4.9) 
N/S Community 
Stebbings et al [31] Cohort New Zealand Mixed 103 (103) 43/ 60 66.0 (9.0) N/S Hospital 
Steigerwald et al [74] RCT Germany Knee 200 (200) 65/135 67.4 (10.8) N/S Hospital 
Sullivan et al [75] RCT USA Mixed 18 (18) 8/10 61.5 (7.9) 8.53 Hospital 
Tonelli et al [76] Cohort USA Knee 208 (208) 
 
70/138 61.9 (10.0) 
61.6 (9.9) 
N/S Hospital 
Tsai et al [77] Cohort Taiwan Mixed 199 (199) 
 
63/136 74.2 (6.1) 
73.1 (5.2) 
N/S Hospital 
Ulus et al [78] RCT Turkey Knee 40 (40) 
 
N/S 60.70 (10.1) 
60.25  (8.8) 
92.25  
120.55  
Hospital 
Wang et al [79] RCT USA Knee 40 
 
10/30 
 
63 (8.1) 
68  (7.0) 
9.7  
 
Hospital 
Weiner et al [25] RCT USA Knee 190 (190) 
 
161/ 29 67.1 (8.9) 
65.8 (8.7) 
66.8 (10.4) 
5.7 
6.2 
7.2 
Hospital 
White et al [80] Cohort USA Knee 1343 (1343) 511/832 63.1 (7.8) N/S Community 
Wilkie et al [7] Cohort UK Mixed lower limb 1053 (1053) 398/655 Range: 50 to 70 N/S Community 
F – females; m – males; N/S – Not stated; OA – osteoarthritis; UK – United Kingdom; USA – United States of America
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Supplement Table 4: Assessment tools for anxiety and depression 
Tool Frequency 
Hospital Anxiety and Depression Score (HADS) 14 
Center for Epidemiologic Studies Depression Scale (CES-D) 11 
Geriatric Depression Scale (GDS) 6 
Beck Depression Inventory (BDI)  6 
State-Trait Anxiety Inventory (STAI) and CES-D 2 
Diagnostic and Statistical Manual of Mental Disorders 4th edition (DSM-IV) 1 
Goldberg Depression Questionnaire  1 
Beck Anxiety Inventory (BAI) and CES-D 1 
Patient Health Questionnaire-9 (PHQ) 1 
PHQ-8 1 
PHQ 1 
Symptom Checklist-20 (SCL) 1 
General Health Questionnaire (GHQ)-12 1 
STAI and GDS 1 
Not clear 1 
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Supplementary Table 5: Meta-analysis results of prevalence of depressive symptoms 
 Number of 
studies 
(n=number 
of 
participants) 
Prevalence  
(95% CI) 
Egger bias  
(p value) 
I2 value (%)  
Prevalence of depressive symptoms 24 (n=10811) 19.9% (15.9-24.5%); 1.22 (p=0.5) 96.1% 
Subgroup Analysis: Knee OA Alone 11 (n=6722) 18.5% (13.8-23.7%) 4.2 (p=0.06) 95.4% 
Subgroup Analysis: Mixed Hip and/or Knee OA 11 (n=4039) 23.0% (16.4-30.2%) 2.74 (p=0.33) 95.8% 
Sub group analyses USA alone 9 (n=6028) 23.1% (14.6-32.8%) 6.34 (p=009) 98.2% 
Sub group analyses Europe only  12 (n=4123) 19.9% (15.8-24.3%) 2.20 (p=0.2) 90% 
CI – confidence intervals; OA – osteoarthritis 
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Supplementary Table 6: Meta-Analysis results of prevalence of anxiety 
 Study 
Number 
(n=number 
participants) 
Prevalence  
(95% CI) 
Egger bias  
(p value) 
I2 value (%)  
Prevalence of anxiety 7 (n=1226) 21.3% (15.5-28.5%) 3.87 (p=0.38) 88.9% 
Subgroup Analysis: Knee OA Alone 4 (n=665) 15.8% (7.5-25.1%) 1.72 (p=0.78) 87.7% 
Subgroup Analysis: Mixed Hip and/or Knee OA 3 (n=315) 28.2% (23.0-33.8%) N/E 12.6% 
Subgroup analyses Europe Only 5 (n=999) 26.6% (21.1-32.4%) 3.07 (p=0.19) 72.1% 
CI – confidence intervals; N/E – Not estimatable; OA – osteoarthritis 
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Supplementary Figure 1: Forest-plot of relative risk of depressive symptoms for people with 
osteoarthritis. 
 
 
 51 
Supplementary Figure 2: Forest-plot of relative risk of anxiety for people with osteoarthritis. 
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